Cerenion granted funding for a 222,000€ project by the European Union
Cerenion Oy to receive significant funding from the European Regional Development Fund of the European Union.
The grant for a project of approximately 222,000€ has been awarded for the development of an ISO13485 -certified Quality Management System, and the related work in seeking the appropriate regulatory approvals and bringing the Cerenion C-Trend™ index to the international market. The non-dilutive funding will assist Cerenion in bringing its innovative brain monitoring technology to market in the European Union in the near future.
"We are grateful to the ERDF, the European Union and the Centre for Economic Development, Transport and the Environment in North Ostrobothnia for this grant. Aided by the grant we feel confident that we can bring our novel solution to the healthcare market in due time and really make a difference in the care of ICU patients.", says Dr. Timo Koskela, CEO of Cerenion.